Dodge & Cox – REGN history
- Issuer:
- Regeneron Pharmaceuticals, Inc.
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 4,458,238
- Current value:
- $3.44B
- Peak shares:
- 4,596,358 (Q4 2025)
- Overall change:
- +88%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 4,458,238 | $3.44B | $772.64 | -138,120 | -3% |
| Q4 2025 | 4,596,358 | $3.55B | $771.87 | +45,513 | +1% |
| Q3 2025 | 4,550,845 | $2.56B | $562.27 | 0 | 0% |
| Q3 2025 | 4,550,845 | $2558.80B | $562270.00 | +724,562 | +19% |
| Q2 2025 | 3,826,283 | $2.01B | $525.00 | 0 | 0% |
| Q2 2025 | 3,826,283 | $2008.80B | $525000.00 | +1,502,198 | +65% |
| Q1 2025 | 2,324,085 | $1.47B | $634.23 | 0 | 0% |
| Q1 2025 | 2,324,085 | $1474.00B | $634230.00 | +2,769 | 0% |
| Q4 2024 | 2,321,316 | $1653.54B | $712330.00 | 0 | 0% |
| Q4 2024 | 2,321,316 | $1.65B | $712.33 | +9,381 | 0% |
| Q3 2024 | 2,311,935 | $2.43B | $1051.24 | -3,751 | 0% |
| Q2 2024 | 2,315,686 | $2.43B | $1051.03 | -44,178 | -2% |
| Q1 2024 | 2,359,864 | $2.27B | $962.49 | -7,816 | 0% |
| Q4 2023 | 2,367,680 | $2.08B | $878.29 | — | NEW |